Bonum Therapeutics, Inc. funding

Bonum Therapeutics, Inc., a biotechnology company based in Seattle, WA (founded 2021), filed a Form D with the SEC on April 17, 2026 and reported $26.9M raised of a $32.3M offering.

Amount raised$26.9M

Offering size$32.3M

Filed with the SECApril 17, 2026

First saleApril 3, 2026

IndustryBiotechnology

SecuritiesEquity

LocationSeattle, WA

Founded2021

Entity typeCorporation

Investors so far8

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 17

Other health care rounds in Washington

Key Proteo, Inc.$2.3M · Oct 23Biotechnology Hexamer Therapeutics, Inc$500K · Sep 15Biotechnology Ora Biomedical, Inc.$205K · Nov 13Biotechnology Seattle Neurosound Solutions, Inc.$100K · Sep 22Other Health Care Q-Immune, Inc.$25K · Sep 28Biotechnology